These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 10565591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy.
    Brigo F, Storti M.
    Cochrane Database Syst Rev; 2013 Nov 19; (11):CD010483. PubMed ID: 24254932
    [Abstract] [Full Text] [Related]

  • 3. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.
    Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G.
    Lancet; 2000 Nov 11; 356(9242):1638-42. PubMed ID: 11089822
    [Abstract] [Full Text] [Related]

  • 4. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.
    Brigo F, Igwe SC.
    Cochrane Database Syst Rev; 2015 Oct 19; (10):CD010483. PubMed ID: 26482210
    [Abstract] [Full Text] [Related]

  • 5. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.
    Brigo F, Igwe SC, Bragazzi NL.
    Cochrane Database Syst Rev; 2017 May 18; 5(5):CD010483. PubMed ID: 28521067
    [Abstract] [Full Text] [Related]

  • 6. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y, Ohtsuka Y, Oguni H, Tohyama J, Baba H, Fukushima K, Ohtani H, Takahashi Y, Ikeda S.
    Epilepsia; 2009 Nov 18; 50(11):2362-8. PubMed ID: 19552653
    [Abstract] [Full Text] [Related]

  • 7. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).
    Plosker GL.
    CNS Drugs; 2012 Nov 18; 26(11):993-1001. PubMed ID: 23018548
    [Abstract] [Full Text] [Related]

  • 8. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T, Yamamoto Y, Fukuda M, Suzuki Y, Imai K, Takahashi Y, Inoue Y, Ohtsuka Y.
    Epilepsy Res; 2017 Feb 18; 130():7-12. PubMed ID: 28081475
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A, Boncristiano A, Doccini V, Pugi A, Pisano T, Lenge M, De Masi S, Guerrini R.
    Epilepsia; 2019 Nov 18; 60(11):2255-2262. PubMed ID: 31630399
    [Abstract] [Full Text] [Related]

  • 10. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr 18; 14(76):57-9. PubMed ID: 15875342
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2015 Jul 18; 113():90-7. PubMed ID: 25986195
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2014 May 18; 108(4):725-31. PubMed ID: 24630050
    [Abstract] [Full Text] [Related]

  • 14. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M, Shimakawa S, Hashimoto T, Kitaoka T, Kyotani S.
    J Clin Pharm Ther; 2018 Aug 18; 43(4):571-573. PubMed ID: 29265387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stiripentol for focal refractory epilepsy.
    Brigo F, Storti M.
    Cochrane Database Syst Rev; 2014 Jan 31; (1):CD009887. PubMed ID: 24488598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep 31; 39(9):952-9. PubMed ID: 9738674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.